4.8 Article

ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function

Journal

NATURE COMMUNICATIONS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms10465

Keywords

-

Funding

  1. National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS07377, NS078375]
  2. Department of Defense [10235006]
  3. Target ALS
  4. Columbia University Center for Motor Neuron Biology and Disease
  5. Medical Scientist Training Program at the Columbia University [T32 GM007367]
  6. NINDS [T32 NS064928-06]
  7. Judith and Jean Pape Adams Charitable Foundation

Ask authors/readers for more resources

Mutations in FUS cause amyotrophic lateral sclerosis (ALS), including some of the most aggressive, juvenile-onset forms of the disease. FUS loss-of-function and toxic gain-of-function mechanisms have been proposed to explain how mutant FUS leads to motor neuron degeneration, but neither has been firmly established in the pathogenesis of ALS. Here we characterize a series of transgenic FUS mouse lines that manifest progressive, mutant-dependent motor neuron degeneration preceded by early, structural and functional abnormalities at the neuromuscular junction. A novel, conditional FUS knockout mutant reveals that postnatal elimination of FUS has no effect on motor neuron survival or function. Moreover, endogenous FUS does not contribute to the onset of the ALS phenotype induced by mutant FUS. These findings demonstrate that FUS-dependent motor degeneration is not due to loss of FUS function, but to the gain of toxic properties conferred by ALS mutations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available